Similarly, the existing provision at section 1847A(c)(5)(C) of the Act, provides authority for CMS to implement the Medicare Part B Drug Inflation Rebate Program using program instruction or other guidance
Retrieved January 21, 2019
Wakefield M, Germain D, Durkin S, Hammond D, Goldberg M, Borland R: Do larger pictorial health warnings diminish the need for plain packaging of cigarettes
Impact of Visual Elements of Tobacco Packaging on Health Risk Perceptions of Youth Groups Yanlong Guo, Yinrui Xu, Denghang Chen International Journal of Environmental Research and Public Health 7
IQOS - smokeless cigarette developed by Philip Morris
If the manufacturer makes a timely request that includes all the supporting documentation, and CMS determines, based on its review of the reduction request and supporting documentation, that a reduction should be granted, CMS would reduce the total rebate amount owed by a manufacturer by 75 percent for the manufacturer's generic Part D rebatable drug for the applicable period in which the request was submitted or the following applicable period, depending on the timing of the submission of the request